According to Ascendis Pharma 's latest financial reports and stock price the company's current number of shares outstanding is 60,018,550. At the end of 2025 the company had 60,018,550 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2025 | 60.01 M | 0.39% |
2024 | 59.78 M | 5.7% |
2023 | 56.56 M | 1.31% |
2022 | 55.83 M | 2.18% |
2021 | 54.63 M | 3.65% |
2020 | 52.71 M | 10.77% |
2019 | 47.59 M | 13.61% |
2018 | 41.88 M | 28.46% |
2017 | 32.6 M | 29.42% |
2016 | 25.19 M | 2.69% |
2015 | 24.53 M | 44.88% |
2014 | 16.93 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Advaxis ADXS | 6,019,063 | -89.97% | ๐บ๐ธ USA |
![]() Affimed
AFMD | 16,100,185 | -73.17% | ๐ฉ๐ช Germany |
![]() Akebia Therapeutics AKBA | 235,497,720 | 292.37% | ๐บ๐ธ USA |